Epidemiological impact of SARS-CoV-2 vaccination: mathematical modeling analyses
Preprint
- 23 April 2020
- preprint
- other
- Published by Cold Spring Harbor Laboratory
Abstract
Background: Several SARS-CoV-2 vaccine candidates are currently in the pipeline. This study aims to inform SARS-CoV-2 vaccine development, licensure, decision-making, and implementation by determining key preferred vaccine product characteristics and associated population-level impact.Methods: Vaccination impact was assessed at various efficacies using an age-structured mathematical model describing SARS-CoV-2 transmission and disease progression, with application for China.Results: A prophylactic vaccine with efficacy against acquisition (VES) of ≥70% is needed to eliminate this infection. A vaccine withVESVESof 50%, number of vaccinations needed to avert one infection is only 2.4, one severe disease case is 25.5, one critical disease case is 33.2, and one death is 65.1. Gains in effectiveness are achieved by initially prioritizing those ≥60 years. Probability of a major outbreak is virtually zero with a vaccine withVES≥70%, regardless of number of virus introductions. Yet, an increase in social contact rate among those vaccinated (behavior compensation) can undermine vaccine impact.Conclusions: Even a partially-efficacious vaccine can offer a fundamental solution to control SARS-CoV-2 infection and at high cost-effectiveness. In addition to the primary endpoint on infection acquisition, developers should assess natural history and disease progression outcomes and/or proxy biomarkers, since such secondary endpoints may prove critical in licensure, decision-making, and vaccine impact.Keywords
Other Versions
- Published version: Version Vaccines, 8, preprints
This publication has 38 references indexed in Scilit:
- A Research Agenda for Helminth Diseases of Humans: Modelling for Control and EliminationPLoS Neglected Tropical Diseases, 2012
- The potential impact of an HIV vaccine with rapidly waning protection on the epidemic in Southern Africa: Examining the RV144 trial resultsVaccine, 2011
- Population Level Impact of an Imperfect Prophylactic Vaccine for Herpes Simplex Virus-2Sexually Transmitted Diseases, 2010
- Predicting the Impact of a Partially Effective HIV Vaccine and Subsequent Risk Behavior Change on the Heterosexual HIV Epidemic in Low- and Middle-Income CountriesJAIDS Journal of Acquired Immune Deficiency Syndromes, 2007
- Perspectives on the basic reproductive ratioJournal of The Royal Society Interface, 2005
- Predicting the Impact of a Nonsterilizing Vaccine against Human Immunodeficiency VirusJournal of Virology, 2004
- Interpretation of serological surveillance data for measles using mathematical models: implications for vaccine strategyEpidemiology and Infection, 1995
- Imperfect vaccines and herd immunity to HIVProceedings. Biological sciences, 1993
- A Comparison of Three Methods for Selecting Values of Input Variables in the Analysis of Output from a Computer CodeTechnometrics, 1979
- THE OUTCOME OF A STOCHASTIC EPIDEMIC—A NOTE ON BAILEY'S PAPERBiometrika, 1955